Cargando…
In melanoma, beta-catenin acts as suppressor of invasion through a cell-type specific mechanism
Cell-type specific signalling determines cell fate under physiological conditions, but it is increasingly apparent that also in cancer development the impact of any given oncogenic pathway on the individual cancer pathology is dependent on cell-lineage specific molecular traits. For instance in colo...
Autores principales: | Arozarena, Imanol, Bischof, Helen, Gilby, Daniel, Belloni, Benedetta, Dummer, Reinhard, Wellbrock, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160497/ https://www.ncbi.nlm.nih.gov/pubmed/21577209 http://dx.doi.org/10.1038/onc.2011.162 |
Ejemplares similares
-
Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion
por: Ferguson, Jennifer, et al.
Publicado: (2012) -
The Complexity of the ERK/MAP-Kinase Pathway and the Treatment of Melanoma Skin Cancer
por: Wellbrock, Claudia, et al.
Publicado: (2016) -
Microphthalmia‐associated transcription factor in melanoma development and MAP‐kinase pathway targeted therapy
por: Wellbrock, Claudia, et al.
Publicado: (2015) -
Glucose availability controls ATF4-mediated MITF suppression to drive melanoma cell growth
por: Ferguson, Jennifer, et al.
Publicado: (2017) -
Differential chemosensitivity to antifolate drugs between RAS and BRAF melanoma cells
por: Arozarena, Imanol, et al.
Publicado: (2014)